Gotham Asset Management, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$298,000
+21.6%
18,994
+32.8%
0.01%0.0%
Q3 2021$245,000
-23.4%
14,299
-3.9%
0.01%
-28.6%
Q2 2021$320,000
+109.2%
14,882
+45.6%
0.01%
+100.0%
Q1 2021$153,000
-17.3%
10,218
-27.3%
0.01%
+16.7%
Q4 2020$185,000
-42.2%
14,057
-57.6%
0.01%
-40.0%
Q3 2020$320,000
-65.3%
33,161
-58.8%
0.01%
-64.3%
Q2 2020$921,000
-43.6%
80,530
-48.9%
0.03%
-37.8%
Q1 2020$1,633,000
-38.3%
157,584
-2.2%
0.04%
-8.2%
Q4 2019$2,645,000
+22.5%
161,192
-0.9%
0.05%
+28.9%
Q3 2019$2,160,000
+331.1%
162,614
+357.4%
0.04%
+375.0%
Q2 2019$501,000
-38.5%
35,553
-19.7%
0.01%
-33.3%
Q1 2019$815,000
+27.5%
44,282
+81.0%
0.01%
+20.0%
Q4 2018$639,000
-74.9%
24,464
-82.8%
0.01%
-73.0%
Q3 2017$2,545,000
-10.2%
142,159
-18.3%
0.04%
-7.5%
Q2 2017$2,835,000
+20.6%
173,923
+3.6%
0.04%
+33.3%
Q1 2017$2,351,000
+144.9%
167,953
+178.9%
0.03%
+150.0%
Q4 2016$960,000
+111.9%
60,217
+121.0%
0.01%
+100.0%
Q3 2016$453,000
+183.1%
27,244
+90.5%
0.01%
+200.0%
Q2 2016$160,00014,3040.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Signpost Capital Advisors, LP 1,688,952$27,327,00010.37%
Palo Alto Investors LP 3,240,424$52,430,0003.90%
Parametrica Management Ltd 12,509$202,0001.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,740,400$28,160,0001.08%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 557,100$9,014,0001.07%
Westend Capital Management, LLC 64,086$841,0001.00%
WALL STREET ASSOCIATES 702,700$11,370,0000.98%
Baker Brothers Advisors 4,372,153$70,741,0000.87%
Iguana Healthcare Management, LLC 100,000$1,618,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,085,301$17,560,0000.71%
View complete list of VANDA PHARMACEUTICALS INC shareholders